|
Volumn 129, Issue 3, 2012, Pages 602-605
|
HPV vaccine recommendations
a a a a a a a a a a a a a
a
NONE
|
Author keywords
Adolescents; Cancer; Females; HPV; Human papillomavirus; Immunization; Males; Vaccine
|
Indexed keywords
HEPATITIS B VACCINE;
RUBELLA VACCINE;
WART VIRUS VACCINE;
AGE;
ANUS CANCER;
BREAST FEEDING;
CANCER SCREENING;
CONDYLOMA ACUMINATUM;
COST EFFECTIVENESS ANALYSIS;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG SAFETY;
HEALTH CARE PLANNING;
HEPATITIS B;
HIGH RISK PATIENT;
HUMAN;
IMMUNIZATION;
IMMUNOCOMPROMISED PATIENT;
IMMUNOGENICITY;
LIVER CIRRHOSIS;
MALE HOMOSEXUAL;
MOUTH CANCER;
NONHUMAN;
PAPILLOMAVIRUS INFECTION;
PATIENT COUNSELING;
PENIS CANCER;
PHARYNX CANCER;
POSTMARKETING SURVEILLANCE;
PRACTICE GUIDELINE;
PREGNANCY;
PREVALENCE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
REVIEW;
RUBELLA;
SEX DIFFERENCE;
SEX RATIO;
SEXUAL BEHAVIOR;
SPONTANEOUS ABORTION;
UTERINE CERVIX CANCER;
ADOLESCENT;
ADVISORY COMMITTEES;
AGE FACTORS;
CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.);
FEMALE;
FORECASTING;
HEALTH POLICY;
HUMANS;
IMMUNIZATION PROGRAMS;
IMMUNIZATION SCHEDULE;
MALE;
PAPILLOMAVIRUS INFECTIONS;
PAPILLOMAVIRUS VACCINES;
PATIENT COMPLIANCE;
PRACTICE GUIDELINES AS TOPIC;
RISK ASSESSMENT;
SEX FACTORS;
UNITED STATES;
|
EID: 84857951007
PISSN: 00314005
EISSN: 10984275
Source Type: Journal
DOI: 10.1542/peds.2011-3865 Document Type: Review |
Times cited : (92)
|
References (6)
|